Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Journal of Respiratory and Critical Care Medicine

• Publication date

  2013-03-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1164/rccm.201210-1928PPPMID 23220921
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• National Heart , Lung , and Blood Institute Workshop Improving Outcomes for Pulmonary Vascular Disease

  2012cited by this paper
• Clinical features of paediatric pulmonary hypertension: a registry study.

  2012cited by this paper
• A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension

  2012cited by this paper
• Survival in Childhood Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management

  2011cited by this paper
• Pulmonary arterial hypertension: a comparison between children and adults

  2011cited by this paper
• A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011

  2011cited by this paper
• Functional classification of pulmonary hypertension in children: Report from the PVRI pediatric taskforce, Panama 2011

  2011cited by this paper
• Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies.

  2010cited by this paper
• Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings.

  2010cited by this paper
• Comparison of 6-min walk test distance and cardiopulmonary exercise test performance in children with pulmonary hypertension

  2010cited by this paper
• Regulation of the pulmonary circulation in the fetus and newborn.

  2010cited by this paper
• Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease

  2010cited by this paper
• Towards improving the care of children with pulmonary hypertension: The rationale for developing a Pediatric Pulmonary Hypertension Network.

  2009cited by this paper
• Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease.

  2009cited by this paper
• Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension.

  2009cited by this paper
• Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001–2006

  2008cited by this paper
• Standard reference for the six-minute-walk test in healthy children aged 7 to 16 years.

  2007cited by this paper
• Oral Sildenafil in Infants With Persistent Pulmonary Hypertension of the Newborn: A Pilot Randomized Blinded Study

  2006cited by this paper
• Beneficial Effect of Oral Sildenafil Therapy on Childhood Pulmonary Arterial Hypertension: Twelve-Month Clinical Trial of a Single-Drug, Open-Label, Pilot Study

  2005cited by this paper
• Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group.

  2000cited by this paper
• Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.

  1997cited by this paper
• Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure.

  1997cited by this paper
• Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the Newborn

  1997cited by this paper

• Testing Higher Doses of Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia: An Open-Label Dose-Finding Phase 1b Clinical Trial (SANE-02).

  2025cites this paper
• Targeted Neonatal Echocardiography in Bronchopulmonary Dysplasia: A Framework for Screening and Management of Chronic Pulmonary Hypertension

  2025cites this paper
• Bosentan in the treatment of persistent pulmonary hypertension in newborns: a systematic review and meta-analysis.

  2024cites this paper
• Optimizing management of chronic pulmonary hypertension in preterm infants: strategies for a complex population

  2024cites this paper
• Pharmacotherapy for Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia: Past, Present, and Future

  2023cites this paper
• Natural Products for the Treatment of Pulmonary Hypertension: Mechanism, Progress, and Future Opportunities

  2023cites this paper
• Comprehensive management for the improved outcome of persistent pulmonary hypertension of the newborn in a one-day-old baby girl: a case report

  2023cites this paper
• Exercise and hypoxia unmask pulmonary vascular disease and right ventricular dysfunction in a 10‐ to 12‐week‐old swine model of neonatal oxidative injury

  2022cites this paper
• The Role of Sildenafil in Treating Brain Injuries in Adults and Neonates

  2022cites this paper
• If We Cannot Use Nitric Oxide for Newborn Persistent Pulmonary Hypertension, is Oral Sildenafil Therapeutic? A Single-center Experience

  2022cites this paper
• The many challenges to the field of pediatric pulmonology posed by pediatric pulmonary hypertension and the path forward

  2021cites this paper
• Pathophysiology and Management of Persistent Pulmonary Hypertension of the Newborn.

  2021cites this paper
• Update on Perioperative Pediatric Pulmonary Hypertension Management.

  2021cites this paper
• Idiopathic Pulmonary Arterial Hypertension in the Pediatric Age Group

  2021cites this paper
• Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment.

  2021cites this paper
• Genetics and Genomics of Pediatric Pulmonary Arterial Hypertension

  2020cites this paper
• Targeted Therapy for Pulmonary Hypertension in Premature Infants

  2020cites this paper
• An update on current and emerging treatments for pulmonary arterial hypertension in childhood and adolescence

  2019cites this paper
• Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017).

  2019cites this paper
• Diagnosis and treatment of pediatric pulmonary arterial hypertension

  2019cites this paper
• Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management

  2019cites this paper
• Sildenafil Use in Children with Pulmonary Hypertension

  2019cites this paper
• Management of Pulmonary Arterial Hypertension in the Pediatric Patient

  2019cites this paper
• Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia.

  2019cites this paper
• Childhood Pulmonary Arterial Hypertension

  2019cites this paper
• Cardiac Physiology and Pharmacology

  2019cites this paper
• Riociguat prevents hyperoxia-induced lung injury and pulmonary hypertension in neonatal rats without effects on long bone growth

  2018cites this paper
• Successful Surgical Repair and Perioperative Management of 6-Month-Old With Total Anomalous Pulmonary Venous Return in a Developing Country: Considerations for the Treatment of Pulmonary Hypertension

  2018cites this paper
• Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi‐Stakeholder Think Tank

  2018cites this paper
• Antenatal Medical Therapies to Improve Lung Development in Congenital Diaphragmatic Hernia

  2018cites this paper
• Myocardial Fistulisation and Coronary Arterial Ectasia in Children with Univentricular Circulation: An Under-Recognised Problem

  2018cites this paper
• Continuous intravenous sildenafil as an early treatment in neonates with congenital diaphragmatic hernia

  2018influential citation
• A Retrospective Review of Infants Receiving Sildenafil.

  2018cites this paper
• Right Heart Failure in Pediatric Pulmonary Hypertension

  2018cites this paper
• Hospital Readmissions in Children with Pulmonary Hypertension: A Multi‐Institutional Analysis

  2018cites this paper
• Congenital Diaphragmatic hernia – a review

  2017cites this paper
• Pediatric Exercise Testing: Value and Implications of Peak Oxygen Uptake

  2017cites this paper
• 155 – Pathophysiology of Persistent Pulmonary Hypertension of the Newborn

  2017cites this paper
• Idiopathic Pulmonary Arterial Hypertension in Children: A Review

  2017cites this paper
• Pulmonary Hypertension Therapy and a Systematic Review of Efficacy and Safety of PDE-5 Inhibitors

  2017cites this paper
• Addressing the challenges of phenotyping pediatric pulmonary vascular disease

  2017cites this paper
• Diagnostic Approach to Pulmonary Hypertension in Premature Neonates

  2017cites this paper
• Characteristics of pediatric pulmonary hypertension trials registered on ClinicalTrials.gov

  2017cites this paper
• Iloprost Drug Delivery during Infant Conventional and High-Frequency Oscillatory Ventilation

  2016cites this paper
• Advances in Neonatal Pulmonary Hypertension

  2016cites this paper
• Pediatric Pulmonary Hypertension.

  2016cites this paper
• Sildenafil Treatment of Infants With Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.

  2016cites this paper
• Update in Pulmonary Vascular Disease 2015.

  2016cites this paper
• Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care Pulmonary Hypertension

  2016cites this paper
• Pulmonary hypertension in the premature infant: a challenging comorbidity in a vulnerable population

  2016cites this paper
• New guidelines for managing pulmonary hypertension: what the pediatrician needs to know

  2016cites this paper
• Executive Summary of the American Heart Association and American Thoracic Society Joint Guidelines for Pediatric Pulmonary Hypertension.

  2016cites this paper
• Pulmonary hypertension associated with acute or chronic lung diseases in the preterm and term neonate and infant. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK

  2016cites this paper
• Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.

  2016cites this paper
• Current Concepts in Management of Pulmonary Hypertension: Fighting the Old Demon with Modern Weapons

  2015cites this paper
• Pulmonary Hypertension and Vascular Abnormalities in Bronchopulmonary Dysplasia.

  2015cites this paper
• Reported Sildenafil Side Effects in Pediatric Pulmonary Hypertension Patients

  2015cites this paper
• Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society

  2015cites this paper
• Insight into Pulmonary Arterial Hypertension Associated with Congenital Heart Disease (PAH-CHD): Classification and Pharmacological Management from a Pediatric Cardiological Point of View.

  2015cites this paper
• Persistent Pulmonary Hypertension of the Newborn.

  2015cites this paper
• Pulmonary hypertension in chronic lung disease of infancy

  2015cites this paper
• Risk-benefit considerations when prescribing phosphodiesterase-5 inhibitors in children

  2015cites this paper
• Sildena fi l Treatment of Infants With Bronchopulmonary Dysplasia – Associated Pulmonary Hypertension

  2015cites this paper
• Drug utilisation profile in the neonatal unit of a university hospital: a prospective observational study in Brazil

  2015cites this paper
• Pulmonary Hypertension in a Premature Infant With Bronchopulmonary Dysplasia.

  2015cites this paper
• Sildenafil in pediatric pulmonary arterial hypertension

  2015cites this paper
• The Real World of Medical Treatment of Pulmonary Arterial Hypertension―Small Evidence, but Heavy Cornerstone―

  2015cites this paper
• [Pulmonary hypertension associated with congenital heart disease and Eisenmenger syndrome].

  2015cites this paper
• Treatment of pulmonary arterial hypertension in children

  2015cites this paper
• Sildenafil Exposure and Hemodynamic Effect After Fontan Surgery

  2014cites this paper
• [Pediatric pulmonary hypertension].

  2014cites this paper
• Extensive coronary arterial fistula development in patients with univentricular circulation

  2014cites this paper
• Sildenafil for the treatment of pulmonary hypertension in children

  2014cites this paper
• Update in pediatric lung disease 2013.

  2014cites this paper
• PULMONARY, SLEEP, AND CRITICAL CARE UPDATE Update in Pulmonary Vascular Diseases 2013

  2014cites this paper
• Progress in the diagnosis and management of pulmonary hypertension in children

  2014cites this paper
• Efficacy of Sildenafil therapy in Paediatrics & Neonates with Pulmonary Artery Hypertension- A study from a Tertiary Care University Hospital

  2014cites this paper
• Oral sildenafil and inhaled iloprost in the treatment of pulmonary hypertension of the newborn

  2014cites this paper
• A new START for Sildenafil in pediatric pulmonary hypertension: reframing the dose-survival relationship in the STARTS-2 trial.

  2014cites this paper
• The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases

  2014cites this paper
• Update in pulmonary vascular diseases 2013.

  2014cites this paper
• Utilisation du sildénafil dans l'hypertension artérielle pulmonaire du prématuré atteint de dysplasie bronchopulmonaire

  2014influential citation
• Oxidative Stress and Therapeutic Development in Lung Diseases

  2014cites this paper
• Sildenafil add-on therapy in paediatric pulmonary arterial hypertension, experiences of a national referral centre

  2014influential citation
• The anesthetic management of children with pulmonary hypertension in the cardiac catheterization laboratory.

  2014cites this paper
• Acute onset of bilateral visual loss during sildenafil therapy in a young infant with congenital heart disease

  2014cites this paper
• Current and advancing treatments for pulmonary arterial hypertension in childhood

  2014cites this paper
• Pediyatrik pulmoner hipertansiyon Pediatric pulmonary hypertension

  2014cites this paper
• Survival Relationship in the STARTS-2 Trial − A New START for Sildenafil in Pediatric Pulmonary Hypertension : Reframing the Dose

  2014cites this paper
• Substantially increased sildenafil bioavailability after sublingual administration in children with congenital heart disease: two case reports

  2014cites this paper
• Drug Treatment of Pulmonary Hypertension in Children

  2014cites this paper
• A Comprehensive Study of Clinical Biomarkers, Use of Inotropic Medications and Fluid Resuscitation in Newborns with Persistent Pulmonary Hypertension

  2014cites this paper
• Pulmonary Hypertension in Preterm Infants with Bronchopulmonary Dysplasia

  2014cites this paper
• Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond

  2013cites this paper
• Nitric oxide deficiency and endothelial dysfunction in pulmonary arterial hypertension.

  2013cites this paper
• Sildenafil zur Behandlung der pulmonalen arteriellen Hypertonie (PAH)

  2013cites this paper
• Neonatal Pulmonary Hypertension

  2013cites this paper
• Temporal trends in use of sildenafil among pediatric patients.

  2013cites this paper
• Disrupted pulmonary artery cyclic guanosine monophosphate signaling in mice with hyperoxia-induced pulmonary hypertension.

  2013cites this paper
• Pharmacokinetic evaluation of sildenafil as a pulmonary hypertension treatment

  2013cites this paper